Pricing Log in Create free account

Capricor Therapeutics, Inc. (CAPR) vs Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY)

Capricor Therapeutics, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are both Biotechnology companies. Capricor Therapeutics, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are of similar size ($572.7M and $524.8M). Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −89,724.2%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 13 metrics below, Capricor Therapeutics, Inc. leads on 7 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 6.

Valuation

Metric CAPR CYVNY Biotechnology median
P/E n/m n/m 10.85
P/S 25.75 2.37 9.49
P/B 2.33 n/m 2.18
Price to free cash flow 4.38 n/m 25.85
EV/EBITDA n/m n/m 0.70
EV/Sales 15.70 759.28 8.99
Earnings yield (24.75%) (2,375.00%) (31.76%)
Free cash flow yield 22.83% (84,379.36%) (21.84%)

Profitability

Metric CAPR CYVNY Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (89,724.18%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.70%) 0.00% (50.82%)
Return on assets (51.53%) 0.00% (46.04%)
Return on invested capital (1,019.73%) 0.00% 0.00%

Growth

Metric CAPR CYVNY Biotechnology median
Revenue growth (TTM) (11.55%) — 6.96%
EPS growth (last fiscal year) (96.52%) 61.59% 29.88%
Revenue growth, 5-year CAGR 85.83% (15.81%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CAPR CYVNY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.35 0.22 4.84
Net debt to EBITDA 2.99 0.31 1.01

Dividend

Metric CAPR CYVNY Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric CAPR CYVNY Biotechnology median
Market cap 572.67m 524.83m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack